Dr. Sulaiman Al Habib Medical Services Group Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Dr. Sulaiman Al Habib Medical Services Group ha aumentado sus beneficios a una tasa media anual de 20.3%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 20.3% anual. Los ingresos han ido creciendo a una tasa media de 15.5% al año. La rentabilidad financiera de Dr. Sulaiman Al Habib Medical Services Group es de 30.8%, y sus márgenes netos son de 21.1%.
Información clave
20.3%
Tasa de crecimiento de los beneficios
20.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Healthcare | 12.3% |
| Tasa de crecimiento de los ingresos | 15.5% |
| Rentabilidad financiera | 30.8% |
| Margen neto | 21.1% |
| Última actualización de beneficios | 30 Sep 2024 |
Actualizaciones de resultados anteriores recientes
Solid Earnings May Not Tell The Whole Story For Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 11
Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08Recent updates
Solid Earnings May Not Tell The Whole Story For Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 11Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Paying Out A Larger Dividend Than Last Year
Nov 07Dr. Sulaiman Al Habib Medical Services Group Company Just Recorded A 9.6% Revenue Beat: Here's What Analysts Think
Nov 06Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Ticks All The Boxes When It Comes To Earnings Growth
Oct 17Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 03Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price
Apr 29There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Mar 15Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15
Feb 22With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Feb 20Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings
Jan 09We Like These Underlying Return On Capital Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 28We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 02Here's Why Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has Caught The Eye Of Investors
Sep 21Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Aug 10Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Well Worth Watching
Jun 17Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Returns At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Are On The Way Up
May 06Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Mar 13Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital Are Heading Higher
Jan 30With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Dec 07Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Oct 23If EPS Growth Is Important To You, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Presents An Opportunity
Sep 08Estimating The Intrinsic Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Aug 24Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching
Aug 08Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward
Jul 12Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?
May 31A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
May 17Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Will Pay A Larger Dividend Than Last Year At ر.س0.83
Apr 28Should You Think About Buying Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Now?
Apr 09Return Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Appealing
Mar 06Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is An Interesting Stock
Feb 16Returns On Capital At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Have Stalled
Dec 05Do Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings Warrant Your Attention?
Nov 17Investors Could Be Concerned With Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Aug 30Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Aug 01Estimating The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Jun 11Capital Allocation Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Ideal
May 27Earnings Beat: Dr. Sulaiman Al Habib Medical Services Group Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 27Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Apr 06A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Feb 04Is Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Shareholder Ownership Skewed Towards Insiders?
Jan 14
Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Is Yielding 1.5% - But Is It A Buy?
Dec 23Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 27Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Dr. Sulaiman Al Habib Medical Services Group. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Sep 24 | 10,558 | 2,227 | 1,333 | 0 |
| 30 Jun 24 | 10,024 | 2,176 | 1,257 | 0 |
| 31 Mar 24 | 9,723 | 2,108 | 1,206 | 0 |
| 31 Dec 23 | 9,508 | 2,046 | 1,158 | 0 |
| 30 Sep 23 | 9,276 | 1,962 | 1,134 | 0 |
| 30 Jun 23 | 8,885 | 1,838 | 1,089 | 0 |
| 31 Mar 23 | 8,627 | 1,750 | 1,069 | 0 |
| 31 Dec 22 | 8,311 | 1,651 | 1,032 | 0 |
| 30 Sep 22 | 8,025 | 1,593 | 971 | 0 |
| 30 Jun 22 | 7,809 | 1,521 | 932 | 0 |
| 31 Mar 22 | 7,547 | 1,448 | 887 | 0 |
| 31 Dec 21 | 7,250 | 1,377 | 850 | 0 |
| 30 Sep 21 | 6,974 | 1,311 | 822 | 0 |
| 30 Jun 21 | 6,761 | 1,261 | 851 | 0 |
| 31 Mar 21 | 6,213 | 1,128 | 796 | 0 |
| 31 Dec 20 | 5,862 | 1,055 | 738 | 0 |
| 30 Sep 20 | 5,575 | 1,008 | 696 | 0 |
| 30 Jun 20 | 5,178 | 907 | 618 | 0 |
| 31 Mar 20 | 5,132 | 883 | 632 | 0 |
| 31 Dec 19 | 5,016 | 870 | 647 | 0 |
| 30 Sep 19 | 4,816 | 825 | 619 | 0 |
| 30 Jun 19 | 4,735 | 835 | 601 | 0 |
| 31 Mar 19 | 4,646 | 819 | 569 | 0 |
| 31 Dec 18 | 4,588 | 801 | 551 | 0 |
| 31 Dec 17 | 4,687 | 658 | 904 | 0 |
| 31 Dec 16 | 4,868 | 1,010 | 959 | 0 |
| 31 Dec 15 | 5,123 | 1,329 | 859 | 0 |
Ingresos de calidad: 4013 tiene un alto nivel de ganancias no monetarias.
Margen de beneficios creciente: Los actuales márgenes de beneficio(21.1%) de 4013 son inferiores a los del año pasado (21.2%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: En los últimos 5 años, los beneficios de l4013 han crecido significativamente en un 20.3% al año.
Acelerando crecimiento: El crecimiento de los beneficios de 4013 en el último año (13.5%) está por debajo de su media de 5 años (20.3% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de 4013 en el último año (13.5%) no superó al de la industria Healthcare 15.7%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera (30.8%) de 4013 se considera alta.